For research use only. Not for therapeutic Use.
Vecuronium(CAT: I037995) is a non-depolarizing neuromuscular blocking agent that acts by competitively inhibiting acetylcholine binding at nicotinic receptors in the neuromuscular junction. This inhibition prevents muscle contraction, leading to reversible skeletal muscle relaxation. Vecuronium is widely utilized in the neurology and anesthesiology fields for research into neuromuscular physiology and the development of muscle relaxants. Its rapid onset and intermediate duration of action make it a valuable tool for studies on receptor pharmacodynamics, drug interactions, and therapeutic strategies involving muscle relaxation in surgical or critical care settings.
Catalog Number | I037995 |
CAS Number | 86029-43-8 |
Synonyms | Vecuronium. |
Molecular Formula | C34H57N2O4+ |
Purity | 98% |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate |
InChI | InChI=1S/C34H57N2O4/c1-23(37)39-31-20-25-12-13-26-27(34(25,4)22-29(31)35-16-8-6-9-17-35)14-15-33(3)28(26)21-30(32(33)40-24(2)38)36(5)18-10-7-11-19-36/h25-32H,6-22H2,1-5H3/q+1/t25-,26+,27-,28-,29-,30-,31-,32-,33-,34-/m0/s1 |
InChIKey | BGSZAXLLHYERSY-XQIGCQGXSA-N |
SMILES | CC(O[C@H]1C[C@@H]2CC[C@@H]3[C@@H]([C@]2(C[C@@H]1N4CCCCC4)C)CC[C@]5([C@H]3C[C@H]([N+]6(CCCCC6)C)[C@@H]5OC(C)=O)C)=O |